Post Profile

With Worrisome Animal Research, More Focus Needed on Effects of Cannabis on Human Development

In this new era of legalized marijuana, far too little research has been conducted on the effect of cannabis on the development of human embryos, say researchers at Georgetown University Medical Center who scoured medical literature on the topic and found what they say is worrisome animal research.
read more


Related Posts

Researchers Identify Potential Treatment for Cognitive Effects of Stress-Related Disorders, including PTSD

Health : Newswise Medical News

Columbia University Medical Center researchers have identified a potential medical treatment for the cognitive effects of stress-related disorders, including post-traumatic stress disorder (PTSD). The study, conducted in a PTSD mous...

Marijuana Compound Treats Schizophrenia with Few Side Effects: Clinical Trial

Health : Time: Healthland

A compound found in marijuana can treat schizophrenia as effectively as antipsychotic medications, with far fewer side effects, according to a preliminary clinical trial. Researchers led by Markus Leweke of the University of Cologne...

New Clinical Trial Will Test Cancer Drug as Alzheimer's Treatment

Health : Newswise Medical News

The Alzheimer's Drug Discovery Foundation (ADDF) announces a $2.1 million grant awarded to R. Scott Turner, MD, PhD, of Georgetown University Medical Center to conduct a phase II clinical trial of low-dose nilotinib (marketed as Tas...

Study Shows Long-Term Effectiveness Of New Family Planning Method

Health : Medical News Today

A simple-to-use, fertility-awareness based method of family planning developed by researchers from the Institute for Reproductive Health at Georgetown University Medical Center so effectively meets the needs of users that they conti...

Georgetown Receives FDA Clearance to Conduct Clinical Trial with Nilotinib in Alzheimer's Disease

Health : Newswise Medical News

Georgetown University Medical Center today announces the U.S. Food and Drug Administration has completed its review of an investigational new drug application (IND) for the use of nilotinib in a phase II clinical trial for patients ...


Copyright © 2016 Regator, LLC